Cizzle Biotechnology has been granted Canadian patent protection for methods measuring the CIZ1B lung cancer biomarker, strengthening its intellectual property portfolio...
Quadrise plc announces the release of its Sustainability Report 2025, reporting a 21% reduction in operational emissions intensity, successful engine trials of MSAR® and bioMSAR™, and continued progress toward commercial deployment across shipping and international energy projects...
REACT Group plc, the specialist support services provider to the FM industry, confirms that its final results for the year ended 30 September 2025 will be released on Thursday, 5 February 2026...
Billington Holdings Plc has announced the appointment of Sharon Daly as an Independent Non-Executive Director and Chair of the Remuneration Committee, effective 2 February 2026...
XP Factory delivered record quarterly sales over the 2025/26 festive period, with UK owned and operated revenue rising 4.2% in the 13 weeks to 28 December 2025...
Hercules plc has announced that its power and energy subsidiary, Advantage NRG, has secured contracts worth approximately £6.5m across two UK electricity networks...
During the October–December 2025 quarter, Thor Energy advanced its HY-Range natural hydrogen and helium project toward drill readiness, completed key non-dilutive asset monetisations, and reinforced its exposure to South Australian copper-gold assets...
NB Private Equity is accelerating buybacks, funding new investments, and holding steady on a 3%+ yield — all backed by a maturing portfolio and stable 20% expected returns. Analyst Mark Thomas explains why the market may be overlooking just how strong the fundamentals are...
Ilika plc CEO Graeme Purdy confirms that the Stereax M300 — their miniature solid-state battery — is now in commercial production via Cirtec Medical in the US. With 21 customers lined up and applications ranging from pain neurostimulators to smart orthodontics, this marks a major milestone for the company...
Cora Gold CEO Bert Monro outlines how fresh funding will accelerate permitting at the Sanankoro Gold Project in Mali — and why signs from the government are giving the company new momentum heading into 2026..
Oriole Resources (AIM: ORR) is advancing Cameroon’s first-ever JORC-defined gold project at Bibemi. CEO Martin Rosser reveals how a high-confidence starter scenario, backed by ministerial support, could fast-track development and open the door to a much larger gold district...
Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing...
CMC Markets’ CEO Lord Peter Cruddas argues it’s time for a market re-rating. With $150bn in client assets and global tech deals from Westpac to Revolut, the business is no longer just a B2C trading firm—it’s a tech-driven financial engine...
Escape Hunt drives XP Factory’s performance with sector-leading margins and positive like-for-likes, while Boom Battle Bar sharpens its rollout strategy and delivers margin gains despite market headwinds...
Elemental Royalty CEO David Cole explains how smart capital allocation and discovery optionality turn modest royalty deals into multi-decade, cash-generating assets with scale...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
NB Private Equity Partners: Analyst Mark Thomas explains how rising exits, midlife co-investments and accelerated buybacks suggest NBPE is on track for a rebound. Could the second half of 2025 be the turning point investors have been waiting for?..
GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...
Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...
Lloyds Banking Group plc delivered a robust financial performance in 2025, with statutory profit before tax rising to £6.7 billion and return on tangible equity reaching 12.9%, or 14.8% excluding one-off charges...
C&C Group plc has announced the appointment of Adam Phillips to its Board as Chief Financial Officer and Executive Director. Adam is expected to join the Company in April 2026, succeeding Andrew Andrea, who will step down from the Board in March 2026...
Gervais Williams highlights the benefits of long-dated, inflation-linked leases, fixed-rate debt, and synergies from the Assura acquisition, which he believes support resilient earnings, dividend growth, and balance sheet strength despite higher interest rates...
Watches of Switzerland Group PLC delivered strong Q3 FY26 performance, with sales growth ahead of expectations across both the US and UK and particularly robust Holiday trading...
Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...
Plus500 has launched event-based contracts on its US B2C platform, Plus500 Futures, marking its entry into the regulated US retail prediction markets segment...
